Publication | Open Access

Proteomics of acute myeloid leukaemia: cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications

Hematological MalignancyChromatinProteomic TechnologyEngineeringMedicineGeneticsMixed-phenotype Acute LeukemiaHematologyAcute Myeloid LeukaemiaPost-translational Protein ModificationsCytogenetic Risk GroupsTranslational ProteomicsMolecular DiagnosticsSystems BiologyProteomicsFunctional GenomicsEpigeneticsMyeloid Neoplasia